Edition:
United States

Neuca SA (NEUP.WA)

NEUP.WA on Warsaw Stock Exchange

261.50PLN
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
261.50zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,390
52-wk High
316.50zł
52-wk Low
219.95zł

Chart for

About

Neuca SA is a Poland-based company engaged in the healthcare sector. The Company’s main activities comprise the wholesale of pharmaceuticals; running its own pharmacies under the brand name Synoptis Pharma; provision of advertising, marketing and information technology (IT) services to healthcare market, production of pharmaceut... (more)

Overall

Beta: 0.19
Market Cap(Mil.): zł1,199.25
Shares Outstanding(Mil.): 4.64
Dividend: 6.40
Yield (%): 2.45

Financials

  NEUP.WA Industry Sector
P/E (TTM): 13.92 21.07 36.16
EPS (TTM): 18.79 -- --
ROI: 13.94 10.78 59.05
ROE: 15.01 12.08 71.51

BRIEF-Neuca Q1 Net Profit Up At 31.8 Million Zlotys

* Q1 NET PROFIT 31.8 MILLION ZLOTYS VERSUS 30.2 MILLION ZLOTYS YEAR AGO

May 14 2018

BRIEF-Neuca Plans To Merge With Its Two Wholly Owned Units

* PLANS TO MERGE WITH ITS TWO WHOLLY OWNED UNITS, HURTOWNIA APTEKARZY GALENICA-PANAX AND UNNA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 09 2018

BRIEF-Neuca Buys 100 Pct Shares In Clinmed Pharma

* CLINMED PHARMA DEALS WITH CLINICAL TESTS OF MEDICAL PRODUCTS AND ONCOLOGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 09 2018

BRIEF-Neuca FY Net Profit Down At 94.1 Million Zlotys

* FY REVENUE 7.49 BILLION ZLOTYS VERSUS 7.08 BILLION ZLOTYS YEAR AGO

Mar 16 2018

Earnings vs. Estimates